Influenza Vaccination Receipt in Pediatric Patients With Cancer or Sickle Cell Disease.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
received:
28
10
2021
accepted:
29
07
2022
pubmed:
12
10
2022
medline:
3
3
2023
entrez:
11
10
2022
Statut:
ppublish
Résumé
Influenza causes greater morbidity in children with cancer or sickle cell disease (SCD). Literature on influenza vaccination receipt for these populations is limited in low-vaccination states. Outpatient interventions improve vaccine receipt but isolated inpatient interventions remain unstudied. We reviewed influenza vaccine receipt of children with cancer or SCD treated at Children's Healthcare of Atlanta during three influenza seasons. We implemented a clinical decision support intervention during an influenza season and compared influenza vaccine receipt preintervention and postintervention among admitted children. The oncology cohort (N=1548, 60% to 62%) and the SCD cohort (N=2549, 61% to 65%) had similar-to-higher vaccination receipt to the United States (58% to 64%, P =0.01 to 0.79) and Georgia (51% to 56%, P <0.01). The intervention did not significantly improve vaccination receipt for admitted children with cancer (40% vs. 56%, P =0.05 to 0.88) or SCD (44% vs. 56%, P =0.01). Regression modeling also found no significant increase in vaccine receipt (hematologic malignancy: 0.8 [0.73 to 0.98], solid tumor: 0.9 [0.80 to 1.90], central nervous system tumor: 0.9 [0.71 to 1.14], SCD: 0.9 [0.85 to 0.99]). Children with cancer and SCD have similar-to-greater influenza vaccination receipt compared with Georgia and the United States. An inpatient intervention did not significantly improve influenza vaccine receipt in these patient cohorts. Future studies are needed to identify alternative approaches to improving vaccine receipt in these cohorts.
Sections du résumé
BACKGROUND
Influenza causes greater morbidity in children with cancer or sickle cell disease (SCD). Literature on influenza vaccination receipt for these populations is limited in low-vaccination states. Outpatient interventions improve vaccine receipt but isolated inpatient interventions remain unstudied.
PROCEDURE
We reviewed influenza vaccine receipt of children with cancer or SCD treated at Children's Healthcare of Atlanta during three influenza seasons. We implemented a clinical decision support intervention during an influenza season and compared influenza vaccine receipt preintervention and postintervention among admitted children.
RESULTS
The oncology cohort (N=1548, 60% to 62%) and the SCD cohort (N=2549, 61% to 65%) had similar-to-higher vaccination receipt to the United States (58% to 64%, P =0.01 to 0.79) and Georgia (51% to 56%, P <0.01). The intervention did not significantly improve vaccination receipt for admitted children with cancer (40% vs. 56%, P =0.05 to 0.88) or SCD (44% vs. 56%, P =0.01). Regression modeling also found no significant increase in vaccine receipt (hematologic malignancy: 0.8 [0.73 to 0.98], solid tumor: 0.9 [0.80 to 1.90], central nervous system tumor: 0.9 [0.71 to 1.14], SCD: 0.9 [0.85 to 0.99]).
CONCLUSIONS
Children with cancer and SCD have similar-to-greater influenza vaccination receipt compared with Georgia and the United States. An inpatient intervention did not significantly improve influenza vaccine receipt in these patient cohorts. Future studies are needed to identify alternative approaches to improving vaccine receipt in these cohorts.
Identifiants
pubmed: 36219461
doi: 10.1097/MPH.0000000000002559
pii: 00043426-202303000-00023
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e228-e235Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Siegel DA. Geographic variation in pediatric cancer incidence—United States, 2003–2014. MMWR Morb Mortal Wkly Rep. 2018;67:707–713.
Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(suppl 4):S512–S521.
Bundy DG, Strouse JJ, Casella JF, et al. Burden of influenza-related hospitalizations among children with sickle cell disease. Pediatrics. 2010;125:234–243.
Mendoza Sanchez M, Ruiz-Contreras J, Vivanco J, et al. Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol. 2006;28:154–159.
Cost C, Brock E, Adams-Huet B, et al. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer. 2011;56:127–133.
Dotan A, Ben-Shimol S, Fruchtman Y, et al. Influenza A/H1N1 in pediatric oncology patients. J Pediatr Hematol Oncol. 2014;36:e271–e274.
Aydin Koker S, Demirag B, Tahta N, et al. A 3-year retrospective study of the epidemiology of acute respiratory viral infections in pediatric patients with cancer undergoing chemotherapy. J Pediatr Hematol Oncol. 2019;41:e242–e246.
Grohskopf LA. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices—United States, 2020–21 influenza season. MMWR Recomm Rep. 2020;69:1–24.
Kao CM, Lai K, McAteer JM, et al. Influenza vaccine effectiveness and disease burden in children and adolescents with sickle cell disease: 2012-2017. Pediatr Blood Cancer. 2020;67:e28358.
Hambidge SJ, Ross C, Glanz J, et al. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012;129:e54–e59.
Beverung LM, Brousseau D, Hoffmann RG, et al. Ambulatory quality indicators to prevent infection in sickle cell disease. Am J Hematol. 2014;89:256–260.
Freedman JL, Reilly AF, Powell SC, et al. Quality improvement initiative to increase influenza vaccination in pediatric cancer patients. Pediatrics. 2015;135:e540–e546.
Wong CI, Billett AL, Weng S, et al. A quality improvement initiative to increase and sustain influenza vaccination rates in pediatric oncology and stem cell transplant patients. Pediatr Qual Saf. 2018;3:e052.
Cecinati V, Esposito S, Schicchitano B, et al. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies. Hum Vaccin. 2010;6:194–197.
Olshefski RS, Bibart M, Frost R, et al. A multiyear quality improvement project to increase influenza vaccination in a pediatric oncology population undergoing active therapy. Pediatr Blood Cancer. 2018;65:e27268.
Bruce A, Lau S, Reber T, et al. Efficacy of flu vaccination mail-out reminders in pediatric hematology patients for quality improvement: does snailmail still work? J Pediatr Hematol Oncol. 2018;40:629–630.
Orenstein EW, ElSayed-Ali O, Kandaswamy S, et al. Evaluation of a clinical decision support strategy to increase seasonal influenza vaccination among hospitalized children before inpatient discharge. JAMA Netw Open. 2021;4:e2117809.
CDC. Flu Vaccination Coverage, United States, 2019–20 Influenza Season | FluVaxView | Seasonal Influenza (Flu) | CDC. 2020. Available at: https://www.cdc.gov/flu/fluvaxview/coverage-1920estimates.htm . Accessed May 18, 2021.
CDC. Estimated Influenza Illnesses, Medical visits, Hospitalizations, and Deaths in the United States — 2019–2020 Influenza Season. 2020. Available at: https://www.cdc.gov/flu/about/burden/2019-2020.html . Accessed May 18, 2021.
Harris AD, McGregor JC, Perencevich EN, et al. The use and interpretation of quasi-experimental studies in medical informatics. J Am Med Inform Assoc JAMIA. 2006;13:16–23.
Georgia Department of Public Health. Georgia Immunization Registry (GRITS). Available at: https://dph.georgia.gov/immunization-section/georgia-immunization-registry-grits . Accessed July 21, 2021.
R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing https://www.R-project.org/ . Accessed August 15, 2020.
Sobota AE, Kavanagh PL, Adams WG, et al. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015;62:654–657.